NCT07177235View on ClinicalTrials.gov

Ketamine for the Treatment of Refractory Status Epilepticus

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

November 30, 2025

Primary Completion Date

July 31, 2027

Study Completion Date

July 31, 2028

Conditions
Refractory Status Epilepticus
Interventions
DRUG

Ketamine

Timing of ketamine initiation will differ between groups (early versus late ketamine)

DRUG

Midazolam

Midazolam infusion will be initiated at the same time in both groups

Trial Locations (1)

19107

Thomas Jefferson University Hospital, Philadelphia

All Listed Sponsors
lead

Thomas Jefferson University

OTHER